Bristol Myers Squibb · 2 hours ago
Senior Specialist - MSAT Cell Therapy Engineering Support, Process Support
Bothell, WA
Full-time
Onsite
Mid, Senior Level
$90K/yr - $109K/yr
3+ years expBristol Myers Squibb is a company dedicated to transforming patients' lives through science. The Senior Specialist - MSAT Cell Therapy Engineering Support role focuses on providing product and process support for cell therapy manufacturing operations, ensuring quality and efficiency in production processes.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Functions as a technology, product, and process subject matter expert; may serve as system SME on one or more manufacturing unit operations or families of equipment
Provides on-the-floor and on-site/remote troubleshooting and technical support (including on-call coverage outside of business hours)
Facilitates deviation prevention and deviation closure through site quality systems
Analyzes and summarizes manufacturing data to support impact assessments and investigations
Supports site risk assessment program and owns MSAT related risk assessment documentation, as applicable
Analyzes trends of clinical and commercial production data to drive actions for manufacturing process improvement
Uses continuous improvement/lean tools to identify opportunities for process improvements and operational efficiencies, and drives cross-functional projects to implement
Represents MSAT when interfacing with other local and global functional teams
Qualification
Required
Demonstrated problem-solving skills, including issue resolution, root cause investigations
Demonstrated ability to effectively work in and lead cross functional teams, meet deadlines, and prioritize multiple projects
Able to apply engineering principles and statistical analysis to resolve processing issues and evaluate process improvement opportunities
Demonstrated scientific and technical acumen including technical writing skills
BS and/or MS degree in Science or Chem/Bio Engineering
3+ years relevant experience in biologics or cell therapy manufacturing or development with BS, or 2+ years relevant experience with MS
Preferred
Immunology education preferred
Preferred experience: cGMP, Lean/six sigma
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
2026-01-09
2026-01-08
Company data provided by crunchbase